Cefalexin (Cephalexin)
Brand names: Ceporex, Keflex
Cefalexin is a first-generation oral cephalosporin antibiotic; in this urological context it is used for urinary tract infection and as antibacterial prophylaxis in recurrent UTI. It provides reliable cover against common urinary pathogens.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a beta-lactam that inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins, leading to cell lysis.
Prescribing in practice
- Avoid in patients with a history of immediate or severe hypersensitivity to penicillins or cephalosporins because of cross-reactivity risk.
- Dose adjustment is required in renal impairment as the drug is largely renally excreted; follow the SPC.
- It is unreliable against Pseudomonas and many resistant Gram-negative organisms, so culture and sensitivities should guide prolonged use.
Monitoring
Routine monitoring is not needed for short courses, but renal function and clinical or microbiological response should be reviewed when used for prophylaxis or in impairment.
Counselling the patient
- Complete the prescribed course even if symptoms settle.
- Report rash, swelling, or difficulty breathing as these may signal allergy.
- Diarrhoea is common; seek advice if it is severe or persistent.
Evidence & guidelines
A long-established cephalosporin with extensive clinical use supporting its efficacy in urinary tract infection and UTI prophylaxis.
Reference: NICE NG109 (UTI in adults); NICE NG113 (UTI in under 16s); PHE Antimicrobial Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- First Unprovoked Seizure — Recurrence Risk · Epilepsy
- Epilepsy Risk after First Seizure (MESS Score) · Epilepsy
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections